Developments in the treatment of acute myeloid leukaemia (AML)
20 Jul 2010
Developments in the treatment of acute myeloid leukaemia (AML)
Next generation proteasome inhibitors
Treating bone disease in multiple myeloma
Views on the joint ASCO-ASH education session
Views on the joint ASCO-ASH education session
Frontline treatments for lymphomas
EHA 2010: Experts discuss treatment of elderly cancer patients
Results of the multiple myeloma study comparing zoledronic acid to clodronate
The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma diseases
Progress in myeloma survival rates
Personalised and reduced therapy for Hodgkin's lymphoma
Roundtable discussion on the latest advances in multiple myeloma therapy